Induction Versus Progression of Brain Tumor Development: Differential Functions for the pRB- and p53-Targeting Domains of Simian Virus 40 T Antigen

REFERENCES

• Adams, J. M., and S. Cory. 1991. Transgenic models of tumor development. Science 254:1161–1167.
   PubMed Web of Science ®Google Scholar
• Bookstein, R., and W. Lee. 1991. Molecular genetics of the retinoblastoma suppressor gene. Crit. Rev. Oncogenesis 2:211–227.
   PubMedGoogle Scholar
• Buchkovich, K., L. A. Duffy, and E. Harlow. 1989. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58:1097–1105.
   PubMed Web of Science ®Google Scholar
• Chen, J., K. Neilson, and T. Van Dyke. 1989. Lymphotropic papovavirus early region is specifically regulated in transgenic mice and efficiently induces neoplasia. J. Virol. 63:2204–2214.
   PubMedGoogle Scholar
• Chen, J., G. Tobin, J. M. Pipas, and T. A. Van Dyke. 1992. T antigen mutant activities in transgenic mice: roles of p53 and pRB-binding in tumorigenesis of the choroid plexus. Oncogene 7:1167–1175.
   PubMedGoogle Scholar
• Chen, J., and T. Van Dyke. 1991. Uniform cell-autonomous tumorigenesis of the choroid plexus by papovavirus large T antigens. Mol. Cell. Biol. 11:5968–5976.
   PubMedGoogle Scholar
• Chen, P. L., P. Scully, J. Y. Shew, J. Y. Wang, and W. H. Lee. 1989. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58:1193–1198.
   PubMed Web of Science ®Google Scholar
• Clarke, A. R., E. R. Maandag, M. van Roon, N. M. T. van der Lugt, M. van der Valk, M. L. Hooper, A. Berns, and H. Te Riele. 1992. Requirement for a functional Rb-1 gene in murine development. Nature (London) 359:328–330.
   PubMed Web of Science ®Google Scholar
• Clarke, A. R., C. A. Purdie, D. J. Harrison, R. G. Morris, C. C. Bird, M. L. Hooper, and A. H. Wyllie. 1993. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (London) 362:849–852.
   PubMed Web of Science ®Google Scholar
• Colby, W. W., and T. Shenk. 1982. Fragments of the simian virus 40 transforming gene facilitate transformation of rat embryo cells. Proc. Natl. Acad. Sci. USA 79:5189–5193.
   PubMed Web of Science ®Google Scholar
• Cooper, J. A., and P. Whyte. 1989. RB and the cell cycle: entrance or exit? Cell 58:1009–1011.
   PubMedGoogle Scholar
• Debbas, M., and E. White. 1993. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7:546–554.
   PubMed Web of Science ®Google Scholar
• DeCaprio, J. A., J. W. Ludlow, J. Figge, J. Y. Shew, C. M. Huang, W. H. Lee, E. Marsilio, E. Paucha, and D. M. Livingston. 1988. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54:275–283.
   PubMed Web of Science ®Google Scholar
• DeCaprio, J. A., J. W. Ludlow, D. Lynch, Y. Furukawa, J. Griffin, H. Piwnica Worms, C. M. Huang, and D. M. Livingston. 1989. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58:1085–1095.
   PubMed Web of Science ®Google Scholar
• Diller, L., J. Kassel, C. E. Nelson, M. A. Gryka, G. Litwak, M. Gebhardt, B. Bressac, M. Ozturk, S. J. Baker, B. Vogelstein, and S. H. Friend. 1990. p53 functions as a cell cycle control protein in osteosarcomas. Mol. Cell. Biol. 10:5772–5781.
   PubMed Web of Science ®Google Scholar
• Dobbelstein, M., A. K. Arthur, S. Dehde, K. van Zee, A. Dickmanns, and E. Fanning. 1992. Intracistronic complementation reveals a new function of SV40 T antigen that co-operates with Rb and p53 binding to stimulate DNA synthesis in quiescent cells. Oncogene 7:837–847.
   PubMedGoogle Scholar
• Donehower, L. A., M. Harvey, B. L. Slagle, M. J. McArthur, C. A. J. Montgomery, J. S. Butel, and A. Bradley. 1992. Mice deficient for p53 are developmentally normal but susceptible t spontaneous tumours. Nature (London) 356:215–221.
   PubMed Web of Science ®Google Scholar
• Dowdy, S. F., P. W. Hinds, K. Louie, S. I. Reed, A. Arnold, and R. A. Weinberg. 1993. Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73:499–511.
   PubMed Web of Science ®Google Scholar
• Dyson, N., K. Buchkovich, P. Whyte, and E. Harlow. 1989. The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell 58:249–255.
   PubMedGoogle Scholar
• Erselius, J. R., B. Jostes, A. K. Hatzopoulos, L. Mosthaf, and P. Gruss. 1990. Cell-type-specific control elements of the lymphotropic papovavirus enhancer. J. Virol. 64:1657–1666.
   PubMedGoogle Scholar
• Ewen, M. E., J. W. Ludlow, E. Marsilio, J. A. DeCaprio, R. C. Millikan, S. H. Cheng, E. Paucha, and D. M. Livingston. 1989. An N-terminal transformation-governing sequence of SV40 large T antigen contributes to the binding of both p110Rb and a second cellular protein, pl20. Cell 58:257–267.
   PubMedGoogle Scholar
• Ewen, M. E., H. K. Sluss, C. J. Sherr, H. Matsushime, J. Kato, and D. M. Livingston. 1993. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73:487–497.
   PubMed Web of Science ®Google Scholar
• Fanning, E. 1992. Modulation of cellular growth control by SV40 large T antigen, p. 1–19. In W. Doerfler, and P. Bohm (ed.), Malignant transformation by DNA viruses. VCH, Weinheim, Germany.
   Google Scholar
• Garvin, A. M., K. M. Abraham, K. A. Forbush, A. G. Fair, B. L. Davison, and R. M. Perlmutter. 1990. Disruption of thymocyte development and lymphomagenesis induced by SV40 T-antigen. Int. Immunol. 2:173–180.
   PubMed Web of Science ®Google Scholar
• Goodrich, D. W., N. Ping Wang, Y. Qian, E. Y.-H. Lee, and W. Lee. 1991. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 67:293–302.
   PubMed Web of Science ®Google Scholar
• Gurney, E. G., R. O. Harrison, and J. Fenno. 1980. Monoclonal antibodies against simian virus 40 T antigens: evidence for distinct subclasses of large T antigen and for similarities among nonviral T antigens. J. Virol. 34:752–763.
   PubMed Web of Science ®Google Scholar
• Hamel, P. A., B. L. Gallie, and R. A. Phillips. 1992. The retinoblastoma protein and cell cycle regulation. Trends Genet. 8:180–185.
   PubMed Web of Science ®Google Scholar
• Hanahan, D. 1988. Dissecting multistep tumorigenesis in transgenic mice. Annu. Rev. Genet. 22:479–519.
   PubMed Web of Science ®Google Scholar
• Hanahan, D. 1989. Transgenic mice as probes into complex systems. Science 246:1265–1275.
   PubMed Web of Science ®Google Scholar
• Harlow, E. L., V. Crawford, D. C. Pim, and N. M. Williamson. 1981. Monoclonal antibodies specific for simian virus 40 tumor antigens. J. Virol. 39:861–869.
   PubMed Web of Science ®Google Scholar
• Hinds, P. W., S. Mittnacht, V. Dulic, A. Arnold, S. I. Reed, and R. A. Weinberg. 1992. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993–1006.
   PubMed Web of Science ®Google Scholar
• Hogan, B., F. Costantini, and E. Lacy. 1986. Manipulating the mouse embryo. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
   Google Scholar
• Hollingsworth, R. E., Jr., C. E. Hensey, and W. Lee. 1993. Retinoblastoma protein and the cell cycle. Curr. Opin. Genet. Dev. 50:55–62.
   Google Scholar
• Jacks, T., A. Fazeli, E. M. Schmitt, R. T. Bronson, M. A. Goodell, and R. A. Weinberg. 1992. Effects of an Rb mutation in the mouse. Nature (London) 359:295–300.
   PubMed Web of Science ®Google Scholar
• Kalderon, D., and A. E. Smith. 1984. In vitro mutagenesis of a putative DNA binding domain of SV40 large-T. Virology 139:109–137.
   PubMed Web of Science ®Google Scholar
• Kastan, M. B., O. Onyekwere, D. Sidransky, B. Vogelstein, and R. W. Craig. 1991. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:6304–6311.
   PubMed Web of Science ®Google Scholar
• Kiernan, J. A. 1990. Histological and histochemical methods. Theory and practice. Pergamon Press, Inc., Elmsford, N.Y.
   Google Scholar
• Kierstead, T. D., and M. J. Tevethia. 1993. Association of p53 binding and immortalization of primary C57BL/6 mouse embryo fibroblast by using simian virus 40 T-antigen mutants bearing internal overlapping deletion mutations. J. Virol. 67:1817–1829.
   PubMedGoogle Scholar
• Kohrman, D. C., and M. J. Imperiale. 1992. Simian virus 40 large T antigen stably complexes with a 185-kilodalton host protein. J. Virol. 66:1752–1760.
   PubMedGoogle Scholar
• Kuerbitz, S. J., B. S. Plunkett, W. V. Walsh, and M. B. Kastan. 1992. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA 89:7491–7495.
   PubMed Web of Science ®Google Scholar
• Lane, D. P. 1992. p53, guardian of the genome. Nature (London) 358:15–16.
   PubMed Web of Science ®Google Scholar
• Lane, D. P. 1993. A death in the life of p53. Nature (London) 362:786–787.
   PubMed Web of Science ®Google Scholar
• Lanford, R. E., C. Wong, and J. S. Butel. 1985. Differential ability of a T-antigen transport-defective mutant of simian virus 40 to transform primary and established rodent cells. Mol. Cell. Biol. 5:1043–1050.
   PubMedGoogle Scholar
• Lee, Y. H. P., C. Chang, N. Hu, Y. J. Wang, C. Lai, K. Herrup, W. Lee, and A. Bradley. 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature (London) 359:288–294.
   PubMed Web of Science ®Google Scholar
• Levine, A., J. Momand, and C. Finlay. 1991. The p53 tumour suppressor gene. Nature (London) 351:453–456.
   PubMed Web of Science ®Google Scholar
• Levine, A. J. 1990. The p53 protein and its interactions with the oncogene products of the small DNA tumor viruses. Virology 177:419–426.
   PubMedGoogle Scholar
• Livingston, D., and E. Mihich. 1992. Third Annual Pezcoller Symposium: Tumor Suppressor Genes. Cancer Res. 52:3246–3249.
   PubMedGoogle Scholar
• Livingstone, L. R., A. White, J. Sprouse, E. Livanos, T. Jacks, and T. D. Tlsty. 1992. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70:923–935.
   PubMed Web of Science ®Google Scholar
• Lowe, S. W., and H. E. Ruley. 1993. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev. 7:535–545.
   PubMed Web of Science ®Google Scholar
• Lowe, S. W., E. M. Schmitt, S. W. Smith, B. A. Osborne, and T. Jacks. 1993. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (London) 362:847–849.
   PubMed Web of Science ®Google Scholar
• Manfredi, J. J., and C. Prives. 1990. Binding of p53 and pl05-RB is not sufficient for oncogenic transformation by a hybrid polyoma-virus-simian virus 40 large T antigen. J. Virol. 64:5250–5259.
   PubMedGoogle Scholar
• Mares, V., and Z. Lodin. 1974. An autoradiographic study of DNA synthesis in adolescent and adult mouse forebrain. Brain Res. 76:557–561.
   PubMedGoogle Scholar
• Marshall, C. J. 1991. Tumor suppressor genes. Cell 64:313–326.
   PubMed Web of Science ®Google Scholar
• Marsilio, E., S. H. Cheng, B. Schaffhausen, E. Paucha, and D. M. Livingston. 1991. The T/t common region of simian virus 40 large T antigen contains a distinct transformation-governing sequence. J. Virol. 65:5647–5652.
   PubMedGoogle Scholar
• Martinez, J., I. Georgoff, and A. J. Levine. 1991. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev. 5:151–159.
   PubMed Web of Science ®Google Scholar
• McCarthy, S. A., H. S. Symonds, and T. Van Dyke. Regulation of apoptosis in transgenic mice by SV40 T antigen-mediated inacti-vation of p53. Proc. Natl. Acad. Sci. USA, in press.
   Google Scholar
• Mole, S. E., J. V. Gannon, M. J. Ford, and D. P. Lane. 1987. Structure and function of SV40 large T antigen. Proc. R. Soc. London Ser. B 317:455–469.
   Google Scholar
• Moran, E. 1993. DNA tumor virus transforming proteins and the cell cycle. Curr. Opin. Genet. Dev. 50:63–70.
   Google Scholar
• Palmiter, R. D., and R. L. Brinster. 1986. Germ line transformation of mice. Annu. Rev. Genet. 20:465–499.
   PubMed Web of Science ®Google Scholar
• Perry, M. E., and A. J. Levine. 1993. Tumor-suppressor p53 and the cell cycle. Curr. Opin. Genet. Dev. 3:50–54.
   PubMedGoogle Scholar
• Pipas, J. Unpublished data.
   Google Scholar
• Pipas, J. M., K. W. Peden, and D. Nathans. 1983. Mutational analysis of simian virus 40 T antigen: isolation and characterization of mutants with deletions in the T-antigen gene. Mol. Cell. Biol. 3:203–213.
   PubMed Web of Science ®Google Scholar
• Prives, C., and J. J. Manfredi. 1993. The p53 tumor suppressor protein: meeting review. Genes Dev. 7:529–534.
   PubMed Web of Science ®Google Scholar
• Schmieg, F. I., and D. T. Simmons. 1988. Characterization of the in vitro interaction between SV40 T antigen and p53: mapping the p53 binding site. Virology 164:132–140.
   PubMedGoogle Scholar
• Shaw, P., R. Bovey, S. Tardy, R. Sahli, B. Sordat, and J. Costa. 1992. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc. Natl. Acad. Sci. USA 89:4495–4499.
   PubMed Web of Science ®Google Scholar
• Small, J. A., C. Bieberich, Z. Ghotbi, J. Hess, G. A. Scangos, and J. E. Clements. 1989. The visna virus long terminal repeat directs expression of a reporter gene in activated macrophages, lymphocytes, and the central nervous systems of transgenic mice. J. Virol. 63:1891–1896.
   PubMedGoogle Scholar
• Sompayrac, L., and K. J. Danna. 1988. A new SV40 mutant that encodes a small fragment of T antigen transforms established rat and mouse cells. Virology 163:391–396.
   PubMedGoogle Scholar
• Sompayrac, L., and K. J. Danna. 1991. The amino-terminal 147 amino acids of SV40 large T antigen transform secondary rat embryo fibroblasts. Virology 181:412–415.
   PubMedGoogle Scholar
• Sompayrac, L., and K. J. Danna. 1992. An amino-terminal fragment of SV40 T antigen transforms REF52 cells. Virology 191:439–442.
   PubMedGoogle Scholar
• Spector, R., and C. E. Johanson. 1989. The mammalian choroid plexus. Sci. Am. 261:68–74.
   PubMed Web of Science ®Google Scholar
• Srinivasan, A., K. W. C. Peden, and J. M. Pipas. 1989. The large tumor antigen of simian virus 40 encodes at least two distinct transforming functions. J. Virol. 63:5459–5463.
   PubMed Web of Science ®Google Scholar
• Srinivasan, A., J. M. Pipas, M. T. Saenz Robles, and T. Van Dyke. Unpublished data.
   Google Scholar
• Suda, Y., S. Aizawa, S. Hirai, T. Inoue, Y. Furuta, M. Suzuki, S. Hirohashi, and Y. Ikawa. 1987. Driven by the same Ig enhancer and SV40 T promoter ras induced lung adenomatous tumors, myc induced pre-B cell lymphomas and SV40 large T gene a variety of tumors in transgenic mice. EMBO J. 6:4055–4065.
   PubMed Web of Science ®Google Scholar
• Symonds, H., J. Chen, and T. Van Dyke. 1991. Complex formation between the lymphotropic papovavirus large tumor antigen and the tumor suppressor protein, p53. J. Virol. 65:5417–5424.
   PubMedGoogle Scholar
• Symonds, H. S., S. A. McCarthy, J. Chen, J. M. Pipas, and T. Van Dyke. 1993. Use of transgenic mice reveals cell-specific transformation by a simian virus 40 T-antigen amino-terminal mutant. Mol. Cell. Biol. 13:3255–3265.
   PubMedGoogle Scholar
• Symonds, H. S., and T. Van Dyke. Unpublished data.
   Google Scholar
• Thompson, D. L., D. Kalderon, A. E. Smith, and M. J. Tevethia. 1990. Dissociation of Rb-binding and anchorage-independent growth from immortalization and tumorigenicity using SV40 mutants producing N-terminally truncated large T antigens. Virology 178:15–34.
   PubMedGoogle Scholar
• Ullrich, S. J., W. E. Mercer, and E. Appella. 1992. Human wild-type p53 adopts a unique conformational and phosphorylation state in vivo during growth arrest of glioblastoma cells. Oncogene 7:1635–1643.
   PubMed Web of Science ®Google Scholar
• Van Dyke, T. A. 1994. Analysis of viral-host protein interactions and tumorigenesis in transgenic mice. Semin. Cancer Biol. 5:106.1–106.14.
   Google Scholar
• Weinberg, R. A. 1991. Tumor suppressor genes. Science 254:1138–1146.
   PubMed Web of Science ®Google Scholar
• Yaciuk, P., M. C. Carter, J. M. Pipas, and E. Moran. 1991. Simian virus 40 large-T antigen expresses a biological activity complementary to the p300-associated transforming function of the adenovirus E1A gene products. Mol. Cell. Biol. 11:2116–2124.
   PubMedGoogle Scholar
• Yin, Y., M. A. Tainsky, F. Z. Bischoff, L. C. Strong, and G. M. Wahl. 1992. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70:937–948.
   PubMed Web of Science ®Google Scholar
• Yonish-Rouach, E., D. Grunwald, S. Wilder, A. Kimchi, E. May, J. Lawrence, P. May, and M. Oren. 1993. p53-Mediated cell death: relationship to cell cycle control. Mol. Cell. Biol. 13:1415–1423.
   PubMed Web of Science ®Google Scholar
• Yonish-Rouach, E., D. Resnitzky, J. Lotem, L. Sachs, A. Kimchi, and M. Oren. 1991. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature (London) 352:345–340.
   PubMed Web of Science ®Google Scholar
• Zhu, J., M. Abate, P. W. Rice, and C. N. Cole. 1991. The ability of simian virus 40 large T antigen to immortalize primary mouse embryo fibroblasts cosegregates with its ability to bind to p53. J. Virol. 65:6872–6880.
   PubMedGoogle Scholar
• Zhu, J., P. L. Rice, L. Gorsch, M. Abate, and C. N. Cole. 1992. Transformation of a continuous rat embryo fibroblast cell line requires three separate domains of simian virus 40 large T antigen. J. Virol. 66:2780–2791.
   PubMedGoogle Scholar
• Zhu, L., S. van den Heuvel, K. Helin, A. Fattaey, M. Ewen, D. Livingston, N. Dyson, and E. Harlow. 1993. Inhibition of cell proliferation by pl07, a relative of the retinoblastoma protein. Genes Dev. 7:1111–1125.
   PubMed Web of Science ®Google Scholar